NCCN Guidelines for Patients® | Non-Small Cell Lung Cancer - page 105

105
NCCN Guidelines for Patients
®
: Non-Small Cell Lung Cancer
Version 1.2014
Index
Anxiety
86, 87
Biopsy
18, 19, 22–26, 37 –39
Cancer staging
27–34
Caregivers
90
Chemotherapy
49, 50, 54, 56–68, 71–78
Clinical trials
39, 76, 77, 81
Complementary and alternative medicine
52
Depression
86
Gene changes
9, 38, 39, 72, 74, 78
Imaging tests
13, 16, 17, 20, 23,
36, 37, 41
Lung cancer
7–11
Lymph nodes
10, 24, 32, 45
Maintenance treatment
75
Member Institutions
103, 104
Molecular tests
38
Multiple primary tumors
69
National Comprehensive Cancer Network
4, 100
Nodules
12, 16–19
Panel Members
101, 102
Performance status
71, 72, 74, 76, 77
Pleura
8, 9, 25, 30, 33, 70
Pulmonary function tests
36, 41
Radiation therapy
47, 48, 56–69
Risk factors
13
Screening
4, 17, 20, 80
Side effects
45, 46, 48, 49–51, 71, 85, 87
Sleep
86
Surgery
43–46
Survivorship
79, 80, 87
Supportive care
42, 69, 70, 72, 76, 77
Targeted therapy
42, 50, 51, 54, 78
Treatment options
56–78
Treatment planning
84, 89
1...,95,96,97,98,99,100,101,102,103,104 106,107,108
Powered by FlippingBook